Mark Eisner, EVP and Chief Medical Officer at Vir Biotechnology, Inc. (VIR), sold 5,121 shares at $9.53 ($49K) on 2026-02-24, disclosed to the SEC on 2026-02-26.
Open-market sale of $49k VIR by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.53 | 1,616 | $15K | 31.2% |
| 2 | $9.53 | 1,616 | $15K | 31.2% |
| 3 | $9.82 | 1,889 | $19K | 37.6% |
| Total | $9.64 avg | 5,121 | $49K | 100% |
| Filing → |
| FGEN | SELL | 2023-06-09 | $35K | — | Filing → |
| FGEN | SELL | 2023-06-05 | $21K | — | Filing → |
| FGEN | SELL | 2023-04-06 | $345K | — | Filing → |